[Involvement of scientific societies in early benefit assessment: Simulated participation or valuable additional input?].

Background: The German framework of early benefit assessment (EBA) of drugs also provides for the participation of scientific medical societies. The aim of their inclusion is to assure that care providers can critically assess all aspects of the EBA and provide insights into relevant aspects regarding the provision of care. This study systematically reviews the frequency of participation of the scientific medical societies (FGs) and the Drug Commission of the German Medical Association (AkdÄ) within the scope of the EBA.

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis.

Background And Aim: Oral bisphosphonates have been shown to reduce the risk of fractures in patients with osteoporosis. It can be assumed that the clinical effectiveness of oral bisphosphonates depends on persistence with therapy.

Methods: The influence of persistence with and adherence to oral bisphosphonates on fracture risk in a real-life setting was investigated.